Kanabo Launches eCommerce Platform to Help Improve Wellbeing of Millions of People
23 Mars 2022 - 8:00AM
Business Wire
Unique VapePod device gives consumers metered
dose
First medical grade device of its kind for the
wellness market
Fast acting pure hemp product with no
additives
Kanabo, the UK medicinal cannabis company focusing on the
development and distribution of cannabis-derived products for
medical patients, is launching its eCommerce platform for wellness
CBD consumers.
The Kanabo.store will cater to the UK market initially and then
roll out across Europe, giving CBD consumers access to Kanabo’s
three proprietary CBD formula pods that work with Kanabo’s unique
VapePod, the first of its kind medical grade vaporiser that
provides easy-to-use metered dosing.
Relax helps you quiet your mind and find your inner
tranquility with a calming blend of CBD and carefully chosen
terpenes, Reload resets your clarity and focus with a
stimulating blend of CBD and reinvigorating terpenes while
Repair helps release your tension, regain your balance and
get back on track with a powerful blend of CBD, CBG and carefully
selected terpenes.
The world renowned R&D team at Kanabo, the first medicinal
cannabis company to IPO on the London Stock Exchange, has made the
VapePod a real game changer as it gives a metered dose of 1mg on
every inhalation, so consumers know the exact amount consumed – and
exactly what it is they are inhaling.
Thanks to the rapid onset of cannabinoids delivered to the body
by simply inhaling, the VapePod offers the shortest delivery time
with noticeable effects via the pulmonary tract. The device cuts
out as soon as it reads that 1mg of CBD has been inhaled. The
VapePod’s bioavailability is higher compared to other delivery
methods as the body does not flush out a lot of the product as it
can do with capsules or tinctures.
The CBD Pods are manufactured in the UK and the portable and
easy to use VapePod is discreet for social or work settings. Each
CBD Pod contains 300 doses per unit and the hemp from which our
broad spectrum CBD is made contains minor cannabinoids and hemp
terpenes that are naturally sourced and are manufactured at an
EU-GMP facility, meeting the highest production standards
worldwide. Kanabo’s CBD formulas boast a huge 80% cannabinoids (360
mg of CBD) and are made with only pure hemp ingredients; 100% vegan
and without any commonly added diluents such as harmful PG, VG, MCT
or PEG oils.
Avihu Tamir, founder and CEO of Kanabo, said: “Our VapePod is a
game-changer for CBD consumers who aim to improve their health and
quality of life.
“No other CBD delivery system currently on the market offers the
same precise, metered dosing solution that the VapePod consistently
provides. We use the highest quality hemp-derived natural
ingredients which makes the VapePod the most effective CBD delivery
system in the world.”
The VapePod can also be used for medicinal cannabis as it allows
physicians to now confidently prescribe accurate and precise micro
doses of cannabis and collect accurate patient data.
Link to site: https://www.kanabo.store
For more information, please email press@kanabogroup.com.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20220323005133/en/
Michelle Tamir press@kanabogroup.com
Kanabo (LSE:KNB)
Graphique Historique de l'Action
De Mar 2024 à Avr 2024
Kanabo (LSE:KNB)
Graphique Historique de l'Action
De Avr 2023 à Avr 2024